Muscle Growth & Recovery

A 15-amino-acid fragment derived from a stomach-protecting protein, widely studied in rodents for gut, tendon, and ligament repair.

A synthetic fragment of thymosin beta-4 studied in animals for wound healing, cardiac repair, and tissue regeneration.

A 29-amino-acid GHRH analog formerly FDA-approved for childhood growth hormone deficiency.

A long-acting GHRH analog studied as a research peptide for sustained growth hormone elevation.

A selective ghrelin receptor agonist studied as a growth hormone secretagogue with minimal effects on cortisol or prolactin.

A mitochondrial-encoded peptide studied for its role in metabolism, exercise capacity, and mitochondrial signaling.

A long-acting GHRH analog FDA-approved as Egrifta for HIV-associated visceral fat accumulation.

Mechano Growth Factor (MGF) is a locally-acting splice variant of IGF-1 (IGF-1Ec) studied for its proposed role in activating muscle stem cells and triggering early muscle repair after mechanical loading. Evidence is almost entirely animal and cell-culture based, with no human therapeutic trials.

A popular research-peptide stack pairing the GHRH analog CJC-1295 (no-DAC / Mod GRF 1-29) with the selective secretagogue ipamorelin, intended to amplify natural growth-hormone release. No human trials exist on the combination itself.

A research stack combining tesamorelin (an FDA-approved GHRH analog for HIV-associated visceral fat) with ipamorelin, aimed at fat loss and growth-hormone support. No human trials exist on the combination itself.

A recovery-focused research blend pairing BPC-157 with TB-500, marketed for soft-tissue and injury repair. Both components have only animal-level evidence, and there are no human trials of the combination.

An extended recovery stack adding Mechano Growth Factor (MGF) to the BPC-157 + TB-500 blend, aiming to layer muscle-stem-cell activation onto tissue repair. All three components are animal/lab-level only, with no human or combination trials.